This site is intended for Healthcare Professionals only.

Search here...

Tag: BRCA1 or BRCA2 mutations

NICE rejects use of prostate cancer drug olaparib

News pharmacy.biz Staff pharmacy.biz Staff -
The National Institute for Health and Care Excellence (NICE) has rejected the use of olaparib on the NHS for treatment of adults with hormone-relapsed...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

COVID-19 Inquiry: RPS calls for greater recognition and support for pharmacists

News 0
Despite their crucial role during the pandemic, community pharmacy...

Exclusive: BGMA chief executive on how CPTPP accession will affect UK medicine manufacturers

Features 0
CPTPP membership could attract more suppliers to the UK...

Community pharmacy ‘overlooked’ during pandemic, NPA tells Covid-19 Inquiry

News 0
The NPA asked the Inquiry to consider the resilience...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

NHS to address workforce shortage by recruiting 2,000 doctors from India

News 0
The shortage of doctors in the country is attributed...

LloydsPharmacy confirms exit from the high street

News 0
The chain has closed four stores and sold all...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc

This site is intended for Healthcare Professionals only.